Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01427543 · ClinicalTrials.gov registry record · Phase 3
The HJ MILE HIV Prevention Intervention for Post-incarcerated Men
A Phase 3 study, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 3
- Development phase
- 212
- Enrollment target
NCT01427543: Completed Phase 3 study, sponsored by University of Southern California.
NCT01427543 is a Phase 3 study that has completed, run by University of Southern California. The registered enrollment target is 212 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01427543, a Phase 3 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 212 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether a culturally congruent, group intervention can reduce HIV risk behaviors among recently incarcerated, bisexual, African American men.
Primary Outcome
This measure captures the percentage of times that participants self-report using a condom during vaginal and anal sex.
Interventions
- BEHAVIORAL MILE intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-04 |
| Phase | Phase 3 |
What the finished NCT01427543 record still lists
NCT01427543 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 1 intervention - of which MILE intervention is the first listed.
NCT01427543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01427543 about?
NCT01427543 is a clinical study titled "The HJ MILE HIV Prevention Intervention for Post-incarcerated Men". The goal of this study is to determine whether a culturally congruent, group intervention can reduce HIV risk behaviors among recently incarcerated, bisexual, African American men.
What is the current status of trial NCT01427543?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 212 participants. The study started on 2011-07. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01427543?
The interventions under investigation include: MILE intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01427543?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01427543's enrollment target sits among peer trials
212 1335th of 2000 higher than 664 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia